# A pilot trial of pramlintide home usage in adolescents with type 1 diabetes.

> PubMed lists PMID 19858155 in Pediatrics as Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, with publication-date metadata of 2009-10-26 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-19858155-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-19858155-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-19858155-pramlintide-v1.json
- Content SHA-256: `4c4e2b9e8e852c7d3ccfdcb21f3b75dbf3df0628276e77f687380d9a6468305a`

## Claims and source pins

### Headline

A pilot trial of pramlintide home usage in adolescents with type 1 diabetes. ([`pubmed-observation-pmid-19858155-2026-01-28-6983cb4bd2ed`](#source-pubmed-observation-pmid-19858155-2026-01-28-6983cb4bd2ed))

### Summary

PubMed lists PMID 19858155 in Pediatrics as Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, with publication-date metadata of 2009-10-26 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-19858155-2026-01-28-6983cb4bd2ed`](#source-pubmed-observation-pmid-19858155-2026-01-28-6983cb4bd2ed))

### Paragraph 1

PubMed lists PMID 19858155 in Pediatrics as Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, with publication-date metadata of 2009-10-26 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-19858155-2026-01-28-6983cb4bd2ed`](#source-pubmed-observation-pmid-19858155-2026-01-28-6983cb4bd2ed))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-19858155-2026-01-28-6983cb4bd2ed`](#source-pubmed-observation-pmid-19858155-2026-01-28-6983cb4bd2ed))

## Sources

<a id="source-pubmed-observation-pmid-19858155-2026-01-28-6983cb4bd2ed"></a>
- **A pilot trial of pramlintide home usage in adolescents with type 1 diabetes. · retained source version 1:2026-01-28:current:6983cb4bd2ed2fe7663e758e7c42a6aa519c03211b95cf6b0dd5789198a7ca3d** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/19858155/) (`pubmed-observation-pmid-19858155-2026-01-28-6983cb4bd2ed`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "A pilot trial of pramlintide home usage in adolescents with type 1 diabetes." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-19858155-pramlintide-v1.json SHA-256: 4c4e2b9e8e852c7d3ccfdcb21f3b75dbf3df0628276e77f687380d9a6468305a.